Latest Announcements

SRG Housing Finance Ltd clarifies that it has not received any communication from National Housing Bank regarding a forensic audit, contradicting a news article published in Economic Times.

The board of directors of RGF Capital Markets Ltd has approved the appointment of new directors, including Nishad Jitendra Shah as Managing Director, and the resignation of existing directors, including Sagar Mal Nahata and Sujit Kumar Panda.

Milestone Global Ltd has made a quarterly disclosure regarding defaults on payment of interest/repayment of principal amount on loans from banks/financial institutions and unlisted debt securities.

PFL Infotech Ltd has confirmed that it does not meet the criteria to be classified as a Large Corporate, as per SEBI and BSE circulars, and therefore does not require additional disclosure requirements.

PFL Infotech Ltd has informed BSE that Regulation 57 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 is not applicable to the company as there are no non-convertible securities for which interest/dividend/principal is payable during the quarter.

PFL Infotech Ltd has informed BSE that Regulation 57(5) of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended September 30, 2026, as no non-convertible securities were issued.

Goyal Associates Ltd has announced its 32nd Annual Report for the Financial Year 2025-26, including an increase in authorized capital, appointment of a new company secretary, and notice of the 32nd Annual General Meeting. The company also seeks to shift its registered office and appoint Mr. Ajay Solanki as a director and managing director.

Shree Ganesh Remedies Ltd has announced the resignation of Mr. Aditya Vikrambhai Patel as Company Secretary and Compliance Officer, effective October 03, 2026, and the appointment of Ms. Akanksha as the new Company Secretary and Compliance Officer, effective October 04, 2026.

Avro India Ltd has issued a revised annual report for the financial year 2025-26, correcting errors and omissions in the original report, including incorrect financial information and director appointments.

The Board of Directors of Prabhhans Industries Ltd has approved the proposal for changing the company's name to either 'EXIGO CLEANTECH SOLUTIONS LIMITED', 'EXIGO CLEANTECH LIMITED', or a name approved by the Competent Authority, subject to regulatory approvals.

Transgene Biotek Ltd has informed BSE that Regulation 57(5) of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended September 30, 2026, as no non-convertible securities were issued.

Transgene Biotek Ltd has informed BSE that Regulation 57 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 is not applicable to the company as there are no non-convertible securities for which interest/dividend/principal is payable during the quarter.

Shukra Jewellery Ltd has confirmed that it did not issue any non-convertible securities during the quarter ended 30th September 2026, making Regulation 57(5) of SEBI (LODR) Regulations, 2015 inapplicable.

Shukra Bullions Ltd has confirmed that it has not issued any non-convertible preference shares, NCDs/Bonds, or other non-convertible securities during the quarter ended September 30, 2026, making Regulation 57(5) of SEBI (LODR) 2015 inapplicable.

Aarey Drugs & Pharmaceuticals Ltd has disclosed a shareholding change under SEBI SAST Reg 29(1) 2011, where Nimit Rajesh Ghatalia has acquired 1,50,000 equity shares through warrant conversion, increasing his holding to 5.18%.

Aarey Drugs & Pharmaceuticals Ltd has disclosed under SEBI SAST Regulation 29(2) that promoter group members have acquired additional shares, increasing their combined stake to 42.01%.

Aarey Drugs & Pharmaceuticals Ltd has made a disclosure under SEBI PIT Reg. 2015, stating that promoters have been allotted equity shares due to the conversion of warrants.

Fredun Pharmaceuticals Ltd has allotted 1,82,400 equity shares to non-promoter allottees pursuant to the conversion of 60,800 warrants into equity shares, consequent to the 1:2 bonus issue.

Transgene Biotek Ltd has confirmed that it does not fall under the category of 'Large Corporate' as per SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, and BSE Circular No. LIST/COM/05/2019-20 dated April 11, 2019.

KSS Ltd has been granted a two-month extension for holding its Annual General Meeting (AGM) for the financial year ended 31st March, 2026, due to unforeseen circumstances.